![](/img/cover-not-exists.png)
Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models
Vermaat, J. S., van der Tweel, I., Mehra, N., Sleijfer, S., Haanen, J. B., Roodhart, J. M., Engwegen, J. Y., Korse, C. M., Langenberg, M. H., Kruit, W., Groenewegen, G., Giles, R. H., Schellens, J. H.Volume:
21
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdp559
Date:
July, 2010
File:
PDF, 243 KB
english, 2010